1H magnetic resonance spectroscopy (MRS) of the liver and hepatic malignant tumors at 3.0 Tesla;1H-magnetresonanzspektroskopie (MRS) der leber und von lebermalignomen bei 3,0 Tesla

Radiologe

Volumn 44, Issue 12, 2004, Pages 1192-1196

  Fischbach, F ^a   Thormann, M ^a   Ricke, J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

3 Tesla (T); 1H MRS; Hepatic malignant tumors; High field MRI; Liver

Indexed keywords

ARTICLE; BREATHING; DIAGNOSTIC ACCURACY; HUMAN; LIVER CARCINOMA; PROTON NUCLEAR MAGNETIC RESONANCE; RELIABILITY; SIGNAL NOISE RATIO; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; LIVER; LIVER TUMOR; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; REVIEW; THREE DIMENSIONAL IMAGING;

PROTON;

HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; PROTONS;

EID: 12344321315     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-004-1136-3     Document Type: Article

References (32)

1. Bachert P, Lichy MP (2004) Magnetic resonance spectroscopy. Part 2: application in diagnosis and clinical research. Radiologe 44:81-95
2. Bailes DR, Gilderdale DJ, Bydder GM, Collins AG, Firmin DN (1985) Respiratory ordered phase encoding (ROPE): a method for reducing respiratory motion artefacts in MR imaging. J Comput Assist Tomogr 9:835-838
3. Barany M, Spigos DG, Mok E, Venkatasubramanian PN, Wilbur AC, Langer BG (1987) High resolution proton magnetic resonance spectroscopy of human brain and liver. Magn Reson Imaging 5:393-398
4. Barany M, Langer BG, Glick RP, Venkatasubramanian PN, Wilbur AC, Spigos DG (1988) In vivo H-1 spectroscopy in humans at 1.5 T. Radiology 167:839-844
5. Bell JD, Cox IJ, Sargentoni J, Peden CJ, Menon DK, Foster CS, Watanapa P, Iles RA, Urenjak J (1993) A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver. Biochim Biophys Acta 1225:71-77
6. Brown TR, Kincaid BM, Ugurbil K (1982) NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci U S A 79:3523-3526
7. Cho SG, Kim MY, Kim HJ, Kim YS, Choi W, Shin SH, Hong KC, Kim YB, Lee JH, Suh CH (2001 ) Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 221:740-746
8. Dixon RM (1998) NMR studies of phospholipid metabolism in hepatic lymphoma. NMR Biomed 11:370-379
9. Earls JP, Rofsky NM, Decorate DR, Krinsky GA, Weinreb JC (1999) Echo-train STIR MRI of the liver: comparison of breath-hold and non-breath-hold imaging strategies. J Magn Reson Imaging 9:87-92
10. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R (1989) Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 9:79-93
11. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R (1989) Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 11:47-63
12. Gaa J, Hatabu H, Jenkins RL, Finn JP, Edelman RR (1996) Liver masses: replacement of conventional T2-weighted spin-echo MR imaging with breath-hold MR imaging. Radiology 200:459-464
13. Gruetter R, Weisdorf SA, Rajanayagan V, Terpstra M, Merkle H, Truwit C L, Garwood M, Nyberg SL, Ugurbil K (1998) Resolution improvements in in vivo 1H NMR spectra with increased magnetic field strength. J Magn Reson 135:260-264
14. Haussinger D, Schliess F, Warskulat U, Vom DS (1997) Liver cell hydration. Cell Biol Toxicol 13:275-287
15. Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC (2004) In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging 19:598-604
16. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW (2002) High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222:715-721
17. Longo R, Ricci C, Masutti F, Vidimari R, Croce LS, Bercich L, Tiribelli C, Dalla PL (1993) Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 28:297-302
18. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N (1999) Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107:450-455
19. McConnell MV, Khasgiwala VC, Savord BJ, Chen MH, Chuang ML, Edelman RR, Manning WJ (1997) Comparison of respiratory suppression methods and navigator locations for MR coronary angiography. AJR Am J Roentgenol 168:1369-1375
20. Moller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, Zanella FE (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371-381
21. Murphy M, Loosemore A, Clifton AG, Howe FA, Tate AR, Cudlip SA, Wilkins PR, Griffiths JR, Bell BA (2002) The contribution of proton magnetic resonance spectroscopy (1HMRS) to clinical brain tumour diagnosis. Br J Neurosurg 16:329-334
22. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345-1350
23. Podo F (1999) Tumour phospholipid metabolism. NMR Biomed 12:413-439
24. Pouwels PJ, Frahm J (1998) Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 39:53-60
25. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679
26. Ruiz-Cabello J, Cohen JS (1992) Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 5:226-233
27. Salibi N, Brown MA (1998) Clinical MR spectroscopy. First principles. Wiley-Liss, New York
28. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A, Halavaara J, Yki-Jarvinen H (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023-3028
29. Soper R, Himmelreich U, Painter D, Somorjai RL, Lean CL, Dolenko B, Mountford CE, Russell P (2002) Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy. Pathology 34:417-422
30. Star-Lack JM, Adalsteinsson E, Gold GE, Ikeda DM, Spielman DM (2000) Motion correction and lipid suppression for 1H magnetic resonance spectroscopy. Magn Reson Med 43:325-330
31. Tarasow E, Siergiejczyk L, Panasiuk A, Kubas B, Dzienis W, Prokopowicz D, Walecki J (2002) MR proton spectroscopy in liver examinations of healthy individuals in vivo. Med Sci Monit 8:MT36-MT40
32. Weber MA, Lichy MP, Thilmann C, Gunther M, Bachert P, Maudsley AA, Delorme S, Schad LR, Debus J, Schlemmer HP (2003) Monitoring of irradiated brain metastases using MR perfusion imaging and 1H MR spectroscopy. Radiologe 43:388-395